GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (XPAR:MEDCL) » Definitions » Other Long-Term Liabilities

Medincell (XPAR:MEDCL) Other Long-Term Liabilities : €8.14 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medincell Other Long-Term Liabilities?

Medincell's other long-term liabilities for the quarter that ended in Mar. 2024 was €8.14 Mil.

Medincell's quarterly other long-term liabilities increased from Mar. 2023 (€0.00 Mil) to Sep. 2023 (€2.83 Mil) and increased from Sep. 2023 (€2.83 Mil) to Mar. 2024 (€8.14 Mil).

Medincell's annual other long-term liabilities declined from Mar. 2022 (€0.02 Mil) to Mar. 2023 (€0.00 Mil) but then increased from Mar. 2023 (€0.00 Mil) to Mar. 2024 (€8.14 Mil).


Medincell Other Long-Term Liabilities Historical Data

The historical data trend for Medincell's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Other Long-Term Liabilities Chart

Medincell Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only - - - - -

Medincell Semi-Annual Data
Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medincell Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Medincell Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Medincell's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Medincell Business Description

Industry
Traded in Other Exchanges
Address
3 rue des Freres Lumiere, Jacou, FRA, 34830
Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell Headlines

No Headlines